Prozess Optimal CAP GmbH
Austria
1 July 2019 - 30 June 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Prozess Optimal CAP GmbH published between 1 July 2019 - 30 June 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 6 | 0.12 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Chemistry | 6 | 0.12 | |
Top articles by Altmetric score in current window
Continuous Flow Synthesis of ZIF-8 Biocomposites with Tuneable Particle Size
Angewandte Chemie International Edition
2020-02-14
HCN on Tap: On-Demand Continuous Production of Anhydrous HCN for Organic Synthesis
Organic Letters
2019-07-05
1 July 2019 - 30 June 2020
International vs. domestic collaboration by Share
- 64.41% Domestic
- 35.59% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (9 total)
- Prozess Optimal CAP GmbH, Austria
- Domestic institution
-
NAWI Graz, Austria
(2.05)
-
Graz University of Technology (TU Graz), Austria
(1.64)
-
University of Graz (Uni Graz), Austria
(1.60)
-
Research Center Pharmaceutical Engineering GmbH (RCPE), Austria
(0.23)
-
Anton Paar GmbH, Austria
(0.23)
-
E.L.T. Kunststofftechnik und Werkzeugbau GmbH, Austria
(0.23)
-
Lithoz GmbH, Austria
(0.23)
-
Microinnova Engineering GmbH, Austria
(0.23)
-
Phyllon GmbH, Austria
(0.23)
Top 10 international collaborators by Share (16 total)
- Prozess Optimal CAP GmbH, Austria
- Foreign institution
-
INSTM - University of Trieste Research Unit (UdR Trieste), Italy
(0.41)
-
The University of Adelaide (Adelaide Uni), Australia
(0.30)
-
Chemtrix B.V., Belgium
(0.23)
-
UCB S.A., Belgium
(0.23)
-
ThalesNano Inc., Hungary
(0.23)
-
Lonza Group Ltd., Switzerland
(0.23)
-
AstraZeneca plc, United Kingdom (UK)
(0.23)
-
Eli Lilly and Company, United States of America (USA)
(0.23)
-
Johnson & Johnson, United States of America (USA)
(0.23)
-
Thermo Fisher Scientific Inc., United States of America (USA)
(0.23)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Affiliated joint institutions and consortia
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
